Transcription factor HOXD13 drives melanoma growth and immune evasion
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’…
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…
RNA micelles enable targeted chemotherapy without immune toxicity
A new study in mice hints at the potential to use tiny particles made with RNA molecules to…
Reprogrammed neutrophils promote tumor growth
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE)…
Novel RNA molecule may influence patient survival in certain blood cancers
In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), researchers at the Texas A&M University Health…
Chemical inhibitor helps viruses overcome bacterial immune defenses
Antimicrobial resistance – when bacteria and fungi defend themselves against the drugs design to kill them – is…
Short-term oatmeal diet improves cholesterol and metabolic health markers
A short-term oat-based diet appears to be surprisingly effective at reducing the cholesterol level. This is indicated by…
New copper-based drug shows promise against antibiotic-resistant MRSA
A research team at the University of Arizona College of Medicine – Tucson is developing a drug that…
Study reveals immune traffic controller hijacked by common virus
In a major scientific breakthrough, researchers from Monash University and the Lions Eye Institute have discovered a tissue…
MIT researchers map dynamic fuzzy coat surrounding tau protein fibrils
One of the hallmarks of Alzheimer’s disease is the clumping of proteins called Tau, which form tangled fibrils…
Preclinical study reveals potential new treatment for severe liver fibrosis
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis – a dangerous, disease-induced build-up of…